Quantifying pharmaceutical requirements
ثبت نشده
چکیده
20.2 Applications of quantification 20.4 20.3 Issues to consider in quantification 20.5 Preparing an action plan for quantification • Using centralized or decentralized quantification • Using manual or computerized methods for quantification • Estimating the time required • Developing and organizing the medicines list • Filling the supply pipeline • Estimating the procurement period • Considering the effect of lead time • Estimating safety stock • Adjusting for losses and other changes • Cross-checking the results of quantification • Estimating total procurement costs • Adjusting and reconciling final quantities
منابع مشابه
Bank’s Corporate Governance: Quantifying the Effects in Iranian Banking Networks
The most important tool for promoting the bank’s stability and health is the establishment of a standard corporate governance structure for managing the bank's business. Redesigning the relationships between bank management, shareholders and the rest of the bank’s stockholder, including the objectives, the risk and audit indices, and internal control of the bank, is recognized as the foundation...
متن کاملICH Q8: Pharmaceutical Development. Regulatory Requirements Directed by the New Note for Guidance (EMEA/CHMP/167068/2004) in Comparison to the Previous Guideline (CPMP/QWP/155/96). A Critical View from the Generic Pharmaceutical Industry
List of abbreviations 4 Introduction 5 The history and development of the new guideline ICH Topic Q8 5 The contents and requirements according to the new guideline 9 Comparison of the current guideline ICH Q8 with the previous guideline 15 Comparison of both guidelines – a summary 28 The term Design Space-Integration into ICH Q8, Q9 and Q10 29 Requirements of the new guideline for the innovatin...
متن کاملImpact of regulatory requirements on medicine registration in African countries – perceptions and experiences of pharmaceutical companies in South Africa
OBJECTIVE Access to medicines has long been and remains a challenge in African countries. The impact of medicines registration policies in these countries poses a challenge for pharmaceutical companies wanting to register medicines in these countries. The recent AMRHI (African Medicines Registration Harmonisation Initiative) has increased the focus on the need for harmonisation. Medicines regis...
متن کاملThe Development of PAT (Process Analytical Technology) for Drug Production and the Requirements for Domestic Pharmaceutical Engineering Education
After decades of practice and development, the GMP of drug production has entered the cGMP (Current Good Manufacturing Practice) era. In 21st century, PAT has become one of the new trends in the reform of the United States cGMP. In order to learn from foreign pharmaceutical quality control and production management experience, in this paper, the concept of PAT was introduced, the background of ...
متن کاملUsing Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet?
There is emerging interest in the use of discrete choice experiments as a means of quantifying the perceived balance between benefits and risks (quantitative benefit-risk assessment) of new healthcare interventions, such as medicines, under assessment by regulatory agencies. For stated preference data on benefit-risk assessment to be used in regulatory decision making, the methods to generate t...
متن کامل